Ag lódáil…
Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
OBJECTIVE: Previous studies have confirmed the biglycan (BGN) as a core gene in stomach adenocarcinoma (STAD). Present study aimed at conducting further investigations to reveal the potential function of BGN in STAD. METHODS: The mRNA and protein expressions of BGN in STAD were firstly evaluated, fo...
| Príomhchruthaitheoirí: | , , , |
|---|---|
| Formáid: | Online Alt Téacs |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Dove
2021
|
| Ábhair: | |
| Rochtain ar líne: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290488/ https://www.ncbi.nlm.nih.gov/pubmed/34295178 http://dx.doi.org/10.2147/IJGM.S321641 |